News Sentiment

NWRN sentiment intelligence

Newron Pharmaceuticals S.p.A. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 6 relevant articles
Exchange EBS Switzerland
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 11.80 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

68/100 classification confidence.

Company focus 6

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-3.3% over one week, -2.2% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Newron Pharmaceuticals to Make Changes to Phase 3 Trial of Schizophrenia Treatment

Market Reaction

Balanced read

54/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 68/100 classification
One-week reaction -3.3% Price reacting lower
Trend fit Trend inactive -2.2% over four weeks
Fair value 18.4% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 4
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 6
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
marketscreener.com 2
Market source 1
Business Wire 1
simplywall.st 1
StockInvest.us 1

Event Lens

What the news is about

Classified themes
Market update 3
Analyst action 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-6 of 6